CONMED Total Long-Term Assets 2010-2024 | CNMD

CONMED total long-term assets from 2010 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current
CONMED Annual Total Long-Term Assets
(Millions of US $)
2023 $1,684
2022 $1,716
2021 $1,306
2020 $1,335
2019 $1,378
2018 $995
2017 $1,001
2016 $998
2015 $742
2014 $717
2013 $718
2012 $730
2011 $579
2010 $636
2009 $633
CONMED Quarterly Total Long-Term Assets
(Millions of US $)
2024-06-30 $1,662
2024-03-31 $1,674
2023-12-31 $1,684
2023-09-30 $1,700
2023-06-30 $1,707
2023-03-31 $1,710
2022-12-31 $1,716
2022-09-30 $1,718
2022-06-30 $1,495
2022-03-31 $1,297
2021-12-31 $1,306
2021-09-30 $1,311
2021-06-30 $1,319
2021-03-31 $1,322
2020-12-31 $1,335
2020-09-30 $1,339
2020-06-30 $1,345
2020-03-31 $1,358
2019-12-31 $1,378
2019-09-30 $1,359
2019-06-30 $1,362
2019-03-31 $1,370
2018-12-31 $995
2018-09-30 $1,000
2018-06-30 $1,016
2018-03-31 $1,008
2017-12-31 $1,001
2017-09-30 $1,005
2017-06-30 $995
2017-03-31 $995
2016-12-31 $998
2016-09-30 $961
2016-06-30 $968
2016-03-31 $975
2015-12-31 $742
2015-09-30 $710
2015-06-30 $715
2015-03-31 $714
2014-12-31 $717
2014-09-30 $724
2014-06-30 $712
2014-03-31 $715
2013-12-31 $718
2013-09-30 $720
2013-06-30 $724
2013-03-31 $729
2012-12-31 $730
2012-09-30 $744
2012-06-30 $724
2012-03-31 $725
2011-12-31 $579
2011-09-30 $629
2011-06-30 $632
2011-03-31 $634
2010-12-31 $636
2010-09-30 $636
2010-06-30 $638
2010-03-31 $639
2009-12-31 $633
2009-09-30 $635
2009-06-30 $638
2009-03-31 $639
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $2.312B $1.245B
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $78.143B 21.32
Becton Dickinson (BDX) United States $67.812B 17.83
Cardinal Health (CAH) United States $29.438B 15.96
West Pharmaceutical Services (WST) United States $23.723B 48.46
Cooper (COO) United States $20.623B 29.35
Labcorp (LH) United States $20.401B 16.92
Align Technology (ALGN) United States $16.815B 32.18
Henry Schein (HSIC) United States $8.514B 16.22
Merit Medical Systems (MMSI) United States $6.067B 30.98
DENTSPLY SIRONA (XRAY) United States $3.508B 9.54
Patterson (PDCO) United States $1.855B 9.79
STAAR Surgical (STAA) United States $1.499B 55.31
Lifevantage (LFVN) United States $0.176B 23.40
Pro-Dex (PDEX) United States $0.154B 30.74